<SEC-DOCUMENT>0001683168-17-002571.txt : 20171004
<SEC-HEADER>0001683168-17-002571.hdr.sgml : 20171004
<ACCEPTANCE-DATETIME>20171004083009
ACCESSION NUMBER:		0001683168-17-002571
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20171003
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20171004
DATE AS OF CHANGE:		20171004

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SIMULATIONS PLUS INC
		CENTRAL INDEX KEY:			0001023459
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
		IRS NUMBER:				954595609
		FISCAL YEAR END:			0831

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32046
		FILM NUMBER:		171120393

	BUSINESS ADDRESS:	
		STREET 1:		42505 10TH STREET WEST
		CITY:			LANCASTER
		STATE:			CA
		ZIP:			93534-7059
		BUSINESS PHONE:		661-723-7723

	MAIL ADDRESS:	
		STREET 1:		42505 10TH STREET WEST
		CITY:			LANCASTER
		STATE:			CA
		ZIP:			93534-7059
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>simulations_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">UNITED STATES</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SECURITIES AND EXCHANGE COMMISSION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">WASHINGTON, D.C. 20549</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM 8-K</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CURRENT REPORT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">October 3, 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">(Date
of the earliest event reported)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Simulations Plus, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">(Exact
name of registrant as specified in its charter)</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">California</FONT></TD>
    <TD STYLE="width: 33%; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">001-32046</FONT></TD>
    <TD STYLE="width: 33%; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">95-4595609</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">(State or other jurisdiction<BR>
 of incorporation)</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">(Commission<BR>
 File Number)</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">(I.R.S. Employer<BR>
 Identification No.)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">42505 10<SUP>th</SUP> Street West,
Lancaster, California 93534-7059</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">(Address
of principal executive offices) (Zip Code)</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">661-723-7723</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">Registrant's
telephone number, including area code</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left">&#9744;</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal">Written communications pursuant to Rule 425 under
the Securities Act (17 CFR 230.425)</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left">&#9744;</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal">Soliciting material pursuant to Rule 14z-12 under
Exchange Act (17 CFR 240.14a-12)</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left">&#9744;</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal">Pre-commencement communications pursuant to Rule
14d-2(b) under Exchange Act (17 CFR 240.14d-2(b))</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left"><FONT STYLE="font-weight: normal">&#9744;</FONT></TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal">Pre-commencement communications pursuant to Rule
13e-4(c) under Exchange Act (17 CFR 240.13e-4(c))</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.25pt; text-indent: -14.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (&sect;240.12b-2 of this chapter).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">Emerging Growth Company
&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.25pt; text-indent: -14.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. &#9744;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>Item 8.01&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-size: 10pt">Other
Events</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 3, 2017, Simulations Plus, Inc.,
a California corporation (the &quot;Company&quot;), issued a press release announcing preliminary revenues for the fourth fiscal
quarter and fiscal year ended August 31, 2017. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information contained in this Current
Report on Form 8-K shall not be deemed to be &quot;filed&quot; for purposes of Section 18 of the Securities Exchange Act of 1934,
as amended (the &quot;Exchange Act&quot;), or otherwise subject to the liabilities of that section, nor shall such information
be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the &quot;Securities Act&quot;),
or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. The information set forth in
this Current Report on Form 8-K shall not be deemed an admission as to the materiality of any information in this report on Current
Report on Form 8-K that is required to be disclosed solely to satisfy the requirements of Regulation FD.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CAUTION REGARDING FORWARD-LOOKING STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Current Report on Form 8-K may contain
forward-looking statements that are made pursuant to the safe harbor provisions of Section 21E of the Exchange Act. The forward-looking
statements in this Current Report on Form 8-K are not historical facts, do not constitute guarantees of future performance and
are based on numerous assumptions which, while believed to be reasonable, may not prove to be accurate. Any forward-looking statements
in this Current Report on Form 8-K do not constitute guarantees of future performance and involve a number of factors that could
cause actual results to differ materially, including risks more fully described in our most recently filed Quarterly Report on
Form 10-Q and Annual Report on Form 10-K. The Company assumes no obligation to update any forward-looking information contained
in this Current Report or with respect to the announcements described herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 9.01&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial
Statements and Exhibits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.75in; text-indent: -0.75in">99.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="simulations_8k-ex9901.htm">Press release issued on October 3, 2017.</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Value: 2; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIMULATIONS PLUS, INC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: October 4, 2017</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: <U>/s/ John R. Kneisel</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John R. Kneisel</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>simulations_8k-ex9901.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">Exhibit 99.1</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"><IMG SRC="logo.jpg" ALT="">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For Further Information:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Simulations Plus, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">42505 10<SUP>th</SUP> Street West</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Lancaster, CA 93534-7059</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt"><B>CONTACT</B>:</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><U>Simulations Plus Investor Relations</U></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt"><U>Hayden IR</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Ms. Renee Bouche</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Mr. Cameron Donahue</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">661-723-7723</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">651-653-1854</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">renee@simulations-plus.com</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">cameron@haydenir.com</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For Immediate Release:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">October 3, 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>Simulations
Plus Reports Preliminary Revenues for </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>Fourth
Quarter and Fiscal Year 2017</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>Company Reports Record Fourth-Quarter
and Full-Year Revenues</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>LANCASTER, CA, October 3, 2017 &ndash;
</B>Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for
pharmaceutical discovery and development from the earliest discovery through all phases of clinical trials, today released preliminary
revenues for its fiscal fourth quarter (4QFY17) and full fiscal year 2017 (FY2017) ended August 31, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. John R. Kneisel, chief financial officer
of Simulations Plus, stated: &ldquo;This quarter represents the first quarter where we&rsquo;re reporting preliminary consolidated
annual and fourth quarter revenues that include three divisions &ndash; Simulations Plus (Lancaster, CA), Cognigen (Buffalo, NY),
and the newly acquired DILIsym Services, Inc. (Research Triangle Park, NC), which acquisition was completed on June 1, 2017. Net
income will not be released until we complete our annual audit and review of our Annual Report on Form 10-K. We expect to file
our 10-K with the U.S. Securities and Exchange Commission on or before the November 14, 2017, deadline.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Preliminary results for the fiscal year:</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Consolidated software and software-related services increased 7.7% to a record $14.9 million for
FY2017 compared to $13.8 million in FY2016</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Consolidated consulting revenues increased 50.5%, or $3.1 million, to $9.2 million compared to
$6.1 million in FY2016</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Total preliminary consolidated revenues for FY2017 increased 20.9%, or $4.2 million, to a record
$24.1 million, compared to $20.0 million for FY2016</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">For FY2017, approximately 61.7% of revenues came from software licenses and software-related services
and approximately 38.3% of revenues came from consulting studies and collaborations</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">As of August 31, 2017, consolidated cash was $6.2 million after significant cash distributions
made this fiscal year, which included: the final $1 million payment to TSRL in April; approximately $5 million of DILIsym Services,
Inc. acquisition-related payments disbursed subsequent to May 31, 2017; and a distribution of approximately $863,000 in cash dividends
to shareholders on August 4, 2017 (for a total of $3.45 million in dividends distributed to shareholders during FY2017). Cash as
of today is $7.2 million.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Preliminary results for the quarter:</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Consolidated software and software-related services increased 12.2% to a record $2.9 million for
4QFY17 compared to $2.6 million in 4QFY16; DILIsym Services, Inc., accounted for approximately $200,000 of software-related revenues
in this quarter</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Consolidated 4QFY17 consulting revenues increased 144.9%, or $2.0 million, to $3.4 million from
$1.4 million in 4QFY16; DILIsym Services, Inc., accounted for $1.0 million of consulting revenues in this quarter. Buffalo Division
(Cognigen) revenues were up over $800,000 over 4QFY16 and up $400,000 over 3QFY17</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Total preliminary revenues for 4QFY17 increased 58.3% to $6.3 million, a new fourth quarter record,
compared to $4.0 million reported for 4QFY16</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">For the quarter, approximately 46.2% of revenues came from software and software-related services,
and approximately 53.8% of revenues came from consulting studies and collaborations</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">During 4QFY17, the company added 25 new software customers and a total of 88 for FY2017</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Annual recurring customer renewal rate was 88% (total accounts) and 94% based on revenue.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Walt Woltosz, chairman and chief executive
officer of Simulations Plus, added: &ldquo;These results represent solid evidence of the continued strong financial performance
of Simulations Plus in all three divisions. Our scientific and administrative staffs continue to perform as the elite professionals
they are, providing outstanding shareholder value by the excellent products, services, and globally famous support they provide
to our customers. I could not be more proud of our teams in every division. The addition of DILIsym Services, Inc., to the Simulations
Plus family took place at the beginning of our fourth fiscal quarter, and we are already realizing beneficial synergies in products
and services with our new team members, as we have done for the past three years with our Cognigen teammates<FONT STYLE="color: red">.
</FONT>Lancaster and Buffalo have worked together for three years in applying physiologically based pharmacokinetics (PBPK) to
address issues in clinical pharmacology, and Cognigen scientists are now well-trained in applying GastroPlus&trade; PBPK models
in their consulting work. In addition, just since June 1, we are already testing a software methodology for linking our GastroPlus
physiologically based pharmacokinetics (PBPK) outputs to the DILIsym&reg; simulation for drug-induced liver injury. These three
divisions complement each other beautifully, and we expect to see further growth as we work together to provide solutions to our
pharmaceutical, food, cosmetics, and chemical industry customers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: red"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">John Kneisel concluded: &ldquo;Our policy
has been to release preliminary consolidated revenues every quarter; however, as stated in our June 15, 2017, press release, this
is the last quarter where we will release preliminary revenues at the end of the quarter. The growth of the Company and the shifting
of revenue from primarily software (with its straightforward revenue recognition) to an increased percentage of consulting projects
across the three divisions has made the process of compiling revenues more complicated. Beginning with our 2018 fiscal year, our
policy will be to release our final and complete revenues in conjunction with the filing of our quarterly and annual earnings releases
and/or SEC filings-- Forms 10-Q and 10-K.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: red"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Simulations Plus, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Simulations Plus, Inc., is a premier developer
of drug discovery and development software as well as a leading provider of both preclinical and clinical pharmacometric consulting
services for regulatory submissions and quantitative systems pharmacology models for drug-induced liver injury and nonalcoholic
fatty liver disease. The company is a global leader focused on improving the ways scientists use knowledge and data to predict
the properties and outcomes of pharmaceutical, biotechnology, and chemical agents. Our software is licensed to and used in the
conduct of drug research by major pharmaceutical, biotechnology, chemical, and consumer goods companies and regulatory agencies
worldwide. Our innovations in integrating new and existing science in medicinal chemistry, computational chemistry, pharmaceutical
science, biology, and physiology into our software have made us the leading software provider for physiologically based pharmacokinetic
modeling and simulation. For more information, visit our website at www.simulations-plus.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Safe Harbor Statement Under the Private
Securities Litigation Reform Act of 1995</B> &ndash; With the exception of historical information, the matters discussed in this
press release are forward-looking statements that involve a number of risks and uncertainties. Words like &ldquo;believe,&rdquo;
&ldquo;expect&rdquo; and &ldquo;anticipate&rdquo; mean that these are our best estimates as of this writing, but that there can
be no assurances that expected or anticipated results or events will actually take place, so our actual future results could differ
significantly from those statements. Factors that could cause or contribute to such differences include, but are not limited to:
our ability to maintain our competitive advantages, acceptance of new software and improved versions of our existing software by
our customers, the general economics of the pharmaceutical industry, our ability to finance growth, our ability to continue to
attract and retain highly qualified technical staff, our ability to properly manage the new combined company, and a sustainable
market. Further information on our risk factors is contained in our quarterly and annual reports as filed with the U.S. Securities
and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Follow us on Twitter <FONT STYLE="color: blue"><U>| </U></FONT>LinkedIn</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">###</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  O 0@# 2(  A$! Q$!_\0
M'    @,! 0$!            !08  P<$ @@!_\0 /A   0,$ 0($ P4' 0<%
M     0(#!  %!A$A!Q(3,4%1%")A%3)Q@9$(%B-"4J&Q)!<E,T-B<L&"DJ+1
MTO_$ !D!  ,! 0$                "! $#!?_$ "L1  (" 0,# P,$ P
M      $" !$#!!(A$S%!,E%A(G'1%%*!D:'!\?_:  P# 0 "$0,1 #\ ^IG7
M$--J<=6E"$C:E*.@!]32==NI^(6ON$B\LK6/Y64J<W^8&J6OVD;I+A87'B0E
M+2J=)2ROL.BH?T_GL?I65/\ 3;'L<;8&=9:W;YSC8<,.*D%2!]=[J_3Z;&Z!
M\A//8"39<SAMJ#M[S78W6_$GI?@ER2V"=)<4W\IIEB]0L9D<"Y)0KV6A0_\
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M:T?#9FRVO#UO^8@Z'%->)J79,687D&0,7%1))G**4(5L\ >E(^$H2">08RY
MU&HT5*&2K_:(LAMB3<X;3S@!0A;R0I0/EH;KU<+Y:K<ZAN?<8D9Q8VE+KJ4E
M7X;-<]K>T?<(1J50_,C1XAE/R&FXX'<75* 3KWW4:EQWHHE-/MKC%/>'4J!3
MV^^_:LHS;E]2E;,LD8B8+>+K:IC+JF8Z_"=:4% .:X_OJAG2"XSI/3V-<\AG
M%YUY2GB\]I("#K0]!JNG2.S?\U$WC=MCY4H-&RFPR9 8CWFWNO[UX:)"2K?X
M;H7U$SB#A5H$N0@29"EI0B*AP)6H'^;GT&J5<;LP4#DS2Z@63&VI0/'\GMEY
MBPU,RXHE2&DN?#)>2I:21LC0]J$XI&N"LFNTU_)F;G!4>UJ&R$_Z<^Q(]:.F
M1>[BH;QQ4<JE!Y&3V*,\69%XM[3HX*%OI!_3=$FY3#L7XEMYM<?M*O$"@4Z'
MKNE*D=Q-!!EU2ACN06=F&F4[=(2(RE%*75/)"21YC>_.NV)+CS(Z7XCS;["O
MNN-J"DG\Q05(Y(A8,NJ4%DY78(L@L2;U;FG@==BY"0?TW7<_.9-K>F1WFW&D
MM*6EQ"@0=#WK=C>1,W"=E2L8Q)6897&E3(=^,9E#I0$K;!WZ\<?6K9UVRO$L
MAM\:XW-%P:DJ'R=@ (WH_454=&=Q0,+]I*-8-H<J:]YL52L]3>9\KJPY;VI:
MDVR(SWNM#7:3V\[/XT]Q)<>8A2XK[;R4GM);4% 'VJ?)B*5?D7*,>4/=>#4O
MJ50Q-C2'G&F)#3CK?"T)4"4_B*Y)-^M,9XM2+E#:<!UVK>2#_FD"D\ 1BP')
M,)5*KCOM2&@Y'<0ZV?)2#L&I61IC_P"TNM;5@LCS2>]QJ>E:$_U$>E)>77GI
MMF-V3<<I%ZLUZ\)+;S2DA(2 ./Q_&GO]I2/).'09T5!)A34.E6M]GGR?IQ6;
M7K+NGV;2&KAEL"ZV^\^$&W7HRB4*U] ?\U[&E%XE8 \7R.\ARFG(->.\JSK
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MWZ#BT!B8PS"M)274J!VYH '7'TKSF_3VZW'+H>38U=&(=SCM): DME2-#8!
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M')[<*4\7WH2'_P" M1\]I(\CKWI8T7;!/R_)+,YD$&\Q(J#)4&H3C0\+PTK
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$40G_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
